Literature DB >> 11673332

Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes.

D W Zochodne1, V M Verge, C Cheng, H Sun, J Johnston.   

Abstract

Targeting of dorsal root ganglia by diabetes could account for the selective sensory abnormalities that patients with early diabetic polyneuropathy develop. In this work, we addressed survival, phenotype and gene expression in sensory neurones in lumbar dorsal root ganglia in a long-term model of experimental streptozotocin-induced diabetes in rats, designed to reflect human disease. Motor and sensory conduction slowing developed early, by the 2-month time point. At 2 months, sensory neurones had no detectable alterations in their calibre or gene expression, assessed using quantitative in situ hybridization studies for mRNA markers that included alpha CGRP, beta CGRP, NFM, t alpha 1-tubulin, SP, VIP, B50 (GAP43), galanin, somatostatin, PACAP, HSP27, c-jun, SNAP 25, p75, TrkA, TrkB and TrkC. By 12 months, however, diabetics had developed neurone perikaryal and distal axon atrophy, accompanied by generalized downregulation of mRNA expression, particularly of CGRP transcripts, PACAP, SP, NFM, p75, trkA and trkC. With the exception of HSP-27, no elevation in mRNAs that increase after injury, such as VIP, galanin, CCK, PACAP, B50 and t alpha 1-tubulin, was observed and constitutive levels, when detectable, trended towards lower rather than increased levels. There was relative preservation of neurone numbers at 12 months; only a non-significant trend towards fewer diabetic neurones was detected using a rigorous and systematic physical dissector counting approach through the entire L5 ganglia. There was no change in the relative populations of CGRP- and SP-immunoreactive neurones. Our findings indicate that even long-term experimental diabetes is associated with relative preservation of sensory neurone populations, but the neurones are atrophic and their gene expression is altered. This pattern of change differs from that following axotomy, implies a degenerative rather than an injury phenotype and has important implications for how such neurones might be rescued.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673332     DOI: 10.1093/brain/124.11.2319

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  39 in total

1.  Changes in the basal membrane of dorsal root ganglia Schwann cells explain the biphasic pattern of the peripheral neuropathy in streptozotocin-induced diabetic rats.

Authors:  Maria Becker; Tali Benromano; Abraham Shahar; Zvi Nevo; Chaim G Pick
Journal:  J Mol Neurosci       Date:  2014-09-27       Impact factor: 3.444

2.  Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.

Authors:  H Kamiya; W Zhang; A A F Sima
Journal:  Diabetologia       Date:  2006-09-20       Impact factor: 10.122

3.  Schwann cells regulate sensory neuron gene expression before and after peripheral nerve injury.

Authors:  Gunnar Poplawski; Tetsuhiro Ishikawa; Coralie Brifault; Corinne Lee-Kubli; Robert Regestam; Kenneth W Henry; Yasuhiro Shiga; HyoJun Kwon; Seiji Ohtori; Steven L Gonias; Wendy M Campana
Journal:  Glia       Date:  2018-03-09       Impact factor: 7.452

Review 4.  Future treatments for diabetic neuropathy: clues from experimental neuropathy.

Authors:  Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

5.  Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.

Authors:  Hideki Kamiya; Weixian Zhang; Anders A F Sima
Journal:  Exp Diabetes Res       Date:  2009-10-12

6.  A brief review of in vitro models of diabetic neuropathy.

Authors:  Namita G Hattangady; Medha S Rajadhyaksha
Journal:  Int J Diabetes Dev Ctries       Date:  2009-10

7.  Regeneration of diabetic axons is enhanced by selective knockdown of the PTEN gene.

Authors:  Bhagat Singh; Vandana Singh; Anand Krishnan; Kurien Koshy; Jose A Martinez; Chu Cheng; Chris Almquist; Douglas W Zochodne
Journal:  Brain       Date:  2014-02-27       Impact factor: 13.501

8.  Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.

Authors:  James W Russell; Alison Berent-Spillson; Andrea M Vincent; Catherine L Freimann; Kelli A Sullivan; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2008-03-15       Impact factor: 5.996

9.  Intranasal insulin ameliorates experimental diabetic neuropathy.

Authors:  George Francis; Jose Martinez; Wei Liu; Thuhien Nguyen; Amit Ayer; Jared Fine; Douglas Zochodne; Leah R Hanson; William H Frey; Cory Toth
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

10.  Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress.

Authors:  Elena Zherebitskaya; Eli Akude; Darrell R Smith; Paul Fernyhough
Journal:  Diabetes       Date:  2009-02-27       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.